Effects of antihypertensive treatment after acute stroke in the Continue Or Stop post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial
The Lancet NeurologyPublished 11 July 2010
Thompson Robinson, John F. Potter, Gary A. Ford, Christopher J. Bulpitt, Julia Chernova, Carol Jagger
Citations246
SJR quartileQ1
SJR score11.73
SNIP13.75
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Continuation of antihypertensive drugs did not reduce 2-week death or dependency, cardiovascular event rate, or mortality at 6 months, and neutral results might be because COSSACS was underpowered owing to early termination of the trial, and support the continuation of ongoing research trials.
Abstract
The Health Foundation and The Stroke Association.
Keywords
Medicine
The LancetValidity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy
2,546 Citations2000Philip A. Barber, Andrew M. Demchuk +2 more
This CT score is simple and reliable and identifies stroke patients unlikely to make an independent recovery despite thrombolytic treatment as well as primary outcomes, including symptomatic intracerebral haemorrhage and 3-month functional outcome.
Cerebrovascular DiseasesGuidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
2,487 Citations2008Peter A. Ringleb, Marie Germaine Bousser
The article covers referral and emergency management, Stroke Unit service, diagnostics, primary and secondary prevention, general stroke treatment, specific treatment including acute management, management of complications, and rehabilitation.
The LancetThe International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
1,890 Citations1997Peter Sandercock
Aspirinallocated patients had significantly fewer recurrent ischaemic strokes within 14 days with no significant excess of haemorrhagic strokes, so the reduction in death or non-fatal recurrent stroke with aspirin was significant.
The LancetCAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke
1,222 Citations1997Christopher Chen
Taken together, CAST and the similarly large IST show reliably that aspirin started early in hospital produces a small but definite net benefit, with about 9 (SD 3) fewer deaths or non-fatal strokes per 1000 in the first few weeks, and with 13 (5) fewer dead or dependent per 1000 after some weeks or months of follow-up.
StrokeGuidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults
1,125 Citations2007Joseph P. Broderick, Sander Connolly +9 more
Evidence-based guidelines are presented for the diagnosis of intracerebral hemorrhage, the management of increased arterial blood pressure and intracranial pressure, the treatment of medical complications of intrusion, and the prevention of recurrent intrusion.
StrokeBlood Pressure and Clinical Outcomes in the International Stroke Trial
989 Citations2002Jo Leonardi‐Bee, Philip M. Bath +2 more
Both high blood pressure and low blood pressure were independent prognostic factors for poor outcome, relationships that appear to be mediated in part by increased rates of early recurrence and death resulting from presumed cerebral edema in patients with highBlood pressure and increased coronary heart disease events in those with lowBlood pressure.
CirculationGuidelines for the Early Management of Adults With Ischemic Stroke
902 Citations2007Harold P. Adams, Gregory del Zoppo +14 more
The goal is to provide an overview of the current evidence about components of the evaluation and treatment of adults with acute ischemic stroke.
The Lancet NeurologyIntensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial
807 Citations2008Craig S. Anderson, Yining Huang +18 more
Early intensive BP-lowering treatment is clinically feasible, well tolerated, and seems to reduce haematoma growth in ICH, a large randomised trial needed to define the effects on clinical outcomes across a broad range of patients with ICH.
StrokeThe ACCESS Study
650 Citations2003Joachim Schrader, Stephan Lüders +7 more
Early neurohumoral inhibition has similar beneficial effects in cerebral and in myocardial ischemia and when there is need for or no contraindication against early antihypertensive therapy, candesartan cilexetil is a safe therapeutic option according to the ACCESS results.
HypertensionHigh Blood Pressure in Acute Stroke and Subsequent Outcome
611 Citations2003Mark Willmot, Jo Leonardi‐Bee +1 more
High BP in acute ischemic stroke or PICH is associated with subsequent death, death or dependency, and death or deterioration, and moderate lowering of BP might improve outcome.
NeurologyTiming of TIAs preceding stroke
427 Citations2005Peter M. Rothwell, Charles Warlow
In patients presenting with ischemic stroke, TIAs occur most often during the hours and days immediately preceding the stroke.
The LancetMagnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial
399 Citations2004K.W. Muir, Kennedy R. Lees +2 more
Magnesium given within 12 h of acute stroke does not reduce the chances of death or disability significantly, although it may be of benefit in lacunar strokes.
StrokeBlood pressure course in patients with acute stroke and matched controls.
386 Citations1986M Britton, Anders Carlsson +1 more
The natural course of blood pressure was studied after emergency hospitalization in 209 consecutive stroke patients and as many age and sex matched controls and found that stroke patients with previous hypertension had the highest BP levels and previously normotensive controls the lowest.
StrokeBlood Pressure Management in Acute Intracerebral Hemorrhage
377 Citations2004Kazuhiro Ohwaki, Eiji Yano +4 more
The findings suggest that elevated BP increases the risk of hematoma enlargement, and efforts to lower SBP below 150 mm Hg may prevent this risk.
CirculationAcute Hypertensive Response in Patients With Stroke
365 Citations2008Adnan I. Qureshi
Current concepts pertaining to treatment of the acute hypertensive response derived from recent guidelines provided by professional organizations and “best available” evidence derived from experimental and clinical studies are summarized and incorporation of these concepts into clinical practice is discussed.
The Lancet NeurologyControlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial
327 Citations2008John F. Potter, Thompson Robinson +5 more
Early lowering of blood pressure with lisinopril and labetalol after acute stroke seems to be a promising approach to reduce mortality and potential disability, however, care must be taken when these results are interpreted and further evaluation in larger trials is needed.
Cochrane Database of Systematic ReviewsInterventions for deliberately altering blood pressure in acute stroke
214 Citations2014Philip M. Bath, Kailash Krishnan
A Cochrane review of 26 randomised controlled trials of interventions that aimed to alter blood pressure compared with control in participants within one week of acute ischaemic or haemorrhagic stroke to assess the clinical effectiveness of altering blood pressure in people with acute stroke.
Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology
213 Citations2007Harold P. Adams, Gregory del Zoppo +14 more
Journal of the Neurological SciencesCatecholamines, infection, and death in acute ischemic stroke
189 Citations2006Ángel Chamorro, Sergio Amaro +6 more
It is suggested that acute ischemic stroke is associated with an early activation of the sympathetic adrenomedullar pathway that lowers the threshold of infection and increases the risk of death.
StrokeAre Proxy Assessments of Health Status After Stroke With the EuroQol Questionnaire Feasible, Accurate, and Unbiased?
175 Citations1997Paul Dorman, Fiona Waddell +3 more
Moderate agreement between responses from patients and those from their proxies for the more directly observable domains of the EuroQol was found, including the pain and social functioning domains and the psychological functioning domain.
StrokeCardiac Baroreceptor Sensitivity Is Impaired After Acute Stroke
169 Citations1997Thompson Robinson, Martin James +3 more
The impairment of cardiac BRS may be important in explaining the increased BP variability after stroke and this sympathetic predominance in right hemisphere strokes may beImportant in the development of cardiac arrhythmias after stroke.
PubMedInternational Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke.
153 Citations2003Philip M. Bath, John Chalmers +8 more
International Journal of StrokeThe Second (Main) Phase of an Open, Randomised, Multicentre Study to Investigate the Effectiveness of an Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (Interact2)
142 Citations2010Candice Delcourt, Yining Huang +11 more
To compare the effects of a management strategy of early intensive blood pressure lowering with a more conservative guideline-based blood pressure management policy in patients with acute intracerebral hemorrhage, the second, main phase, INTERACT2 is described.
Journal of HypertensionInternational Society of Hypertension (ISH)
139 Citations2003International Society of Hypertension Writing Group
The ISH statement on the management of blood pressure in acute stroke was finalized after presentation and discussion at the World Health Organization and International Society of Hypertension Meeting on Stroke and Blood Pressure, held in Melbourne, Australia, 5-7 December 2002.
NeurosurgeryHISTORY OF THE CUSHING REFLEX
127 Citations2006Harald Fodstad, Patrick J. Kelly +1 more
Harvey Cushing studied the brain's reaction to compression more carefully than previous researchers and offered an improved explanation of the pathophysiology of the phenomenon named after him.
The Lancet NeurologyBlood pressure as a prognostic factor after acute stroke
117 Citations2009Valérie Tikhonoff, Haifeng Zhang +2 more
Present guidelines for the management of blood pressure in patients with acute stroke are not evidence-based, but results from ongoing trials might provide more informed recommendations for the future.
International Journal of StrokeGlyceryl Trinitrate vs. Control, and Continuing vs. Stopping Temporarily Prior Antihypertensive Therapy, in Acute Stroke: Rationale and Design of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial (ISRCTN99414122)
113 Citations2006The ENOS Trial Investigators
ENOS is a prospective international multicentre single-blind randomised-controlled trial in 5000 patients with acute (< 48 h of onset) ischaemic or haemorrhagic stroke and the primary outcome is combined death and dependency at 90 days measured by blinded central telephone follow-up.
StrokeEffect of Telmisartan on Functional Outcome, Recurrence, and Blood Pressure in Patients With Acute Mild Ischemic Stroke
84 Citations2009Philip M. Bath, Renée H. Martin +8 more
Treatment with telmisartan in 1360 patients with acute mild ischemic stroke and mildly elevated BP appeared to be safe with no excess in adverse events, was not associated with a significant effect on functional dependency, death, or recurrence, and modestly lowered BP.
HypertensionRelationship Between Therapeutic Changes in Blood Pressure and Outcomes in Acute Stroke
83 Citations2009Chamila Geeganage, Philip M. Bath
Although large falls or increases in BP are associated with a worse outcome, modest reductions may reduce death and combine death or dependency, although the CIs are wide and compatible with an overall benefit or hazard.
Journal of HypertensionCOSSACS (Continue or Stop post-Stroke Antihypertensives Collaborative Study): rationale and design
58 Citations2005Richard Reading
The primary outcome for COSSACS is the proportion of patients who are dead or dependent at 14 days post-stroke, and secondary outcomes include blood pressure changes, and neurological and functional status at 2 weeks and 6 months post-ictus.
Health Technology AssessmentControlling Hypertension and Hypotension Immediately Post Stroke (CHHIPS) – a randomised controlled trial
56 Citations2009Jane Potter, Amit Mistri +7 more
Oral and sublingual lisinopril and oral and intravenous labetalol are effective BP-lowering agents in acute cerebral infarction and haemorrhage and do not increase the likelihood of early neurological deterioration.
Cochrane Database of Systematic ReviewsVasoactive drugs for acute stroke
50 Citations2010Chamila Geeganage, Philip M. Bath
There is not enough evidence to evaluate reliably the effect of altering BP on outcome after acute stroke, however, treatment with DCLHb was associated with poor clinical outcomes.
Journal of HypertensionEffect of antihypertensive agents on cerebral blood flow and flow velocity in acute ischaemic stroke: systematic review of controlled studies
38 Citations2008Gillian M. Sare, Laura J. Gray +1 more
Cerebrovascular DiseasesAre Simple Questions a Valid Measure of Outcome after Stroke?
34 Citations1997Martin Dennis, Ian Wellwood +1 more
The aim was to farther establish the validity of a novel measure of stroke outcome which has been developed for use in large randomised trials and to identify survivors from a consecutive series of strokes.
Cochrane Database of Systematic ReviewsInterventions for deliberately altering blood pressure in acute stroke
30 Citations2008Chamila Geeganage, Philip M. Bath
There is insufficient evidence to evaluate the effect of altering blood pressure on outcome during the acute phase of stroke, and in patients with acute stroke, CCBs, ACEI, ARA and GTN each lower blood pressure while phenylephrine probably increases blood pressure.